1. Home
  2. Directory
  3. NPI Profile
  4. Prescriptions 1710270780

MRS. IRMARY SANTANA 4624
Prescription History 1710270780
Pharmacist in Toa Baja, PR

NPI Status: Active since May 24, 2011

Contact Information

35 LOS DOMINICOS AVE.
WALGREENS #0082
TOA BAJA, PR
ZIP 00949
Phone: (787) 795-2050
Fax: (787) 795-2052

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MRS. IRMARY SANTANA 4624, an active Pharmacist specialist practicing in Toa Baja, PR. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 253 documented patient claims. Among these therapy options, the most frequently utilized medication is Shingrix, which accounts for 107 claims alone.

Medication Index

A
B
H
S
No matching medications currently found on file.

Alcohol Prep Pads

Generic Formulation: Alcohol Antiseptic PadsSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 58
30-Day Fills 60.0
Days Supply 484
PR State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills27.6
Peer Average Days Supply697
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 123.1% higher than the standard regional baseline profile for PR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $338.46 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.84

State Avg Cost Per Claim

$8.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Alcohol Swabs

Generic Formulation: Alcohol Antiseptic PadsSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 51
30-Day Fills 51.0
Days Supply 368
PR State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills34.1
Peer Average Days Supply772
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 59.4% higher than the standard regional baseline profile for PR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $298.14 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.85

State Avg Cost Per Claim

$4.36

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Boostrix Tdap

Generic Formulation: Diphth,pertuss(Acell),tet VacSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 26
30-Day Fills 26.0
Days Supply 26
PR State Average Benchmarks
Peer Average Claims47.0
Peer Average 30-Day Fills48.7
Peer Average Days Supply86
Conservative Utilization

This provider writes prescriptions for this formulation 44.7% less frequently than the standard regional baseline metric for practitioners inside PR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,682.96 across this reporting matrix range.

Provider Avg Cost Per Claim

$64.73

State Avg Cost Per Claim

$62.08

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Hydrocortisone

Generic Formulation: HydrocortisoneSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 80
PR State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills28.0
Peer Average Days Supply616
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 59.3% less volume than the regional standard for practitioners inside PR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $31.41 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.86

State Avg Cost Per Claim

$25.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.

Therapeutic Applications

Hydrocortisone is a man-made version of a natural substance (cortisol) made by the adrenal gland. This drug is used to treat low cortisol levels caused by diseases of the adrenal gland (such as Addison's disease, adrenocortical insufficiency). Hydrocortisone belongs to a class of drugs known as corticosteroids. Corticosteroids are needed in many ways for the body to function well. They are important for salt and water balance and keeping blood pressure normal.

Shingrix

Generic Formulation: Varicella-Zoster Ge/As01b/PfSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 107
30-Day Fills 107.0
Days Supply 107
PR State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills27.0
Peer Average Days Supply78
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 311.5% higher than the standard regional baseline profile for PR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $21,849.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$204.21

State Avg Cost Per Claim

$191.48

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like MRS. IRMARY SANTANA 4624 provides transparency into local medical care patterns within Toa Baja, PR.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Pharmacist** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.